The board of directors of healthcare company Pfizer Inc (NYSE:PFE) declared an unchanged dividend of USD0.36 per share on the company's common stock, it declared on Tuesday.
Holders of the common stock of record at the close of business as of 8 November 2019 will receive the dividend payment on 2 December 2019.
According to the company, the fourth-quarter 2019 cash dividend will be its 324th consecutive quarterly dividend.
Pfizer said it works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time through collaborations with health care providers, governments and local communities.
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access